References
Sung H, Siegel RL, Rosenberg PS, Jemal A. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Health. 2019;4(3):e137–47.
Matsuo K, Gualtieri MR, Cahoon SS, et al. Surgical menopause and increased risk of non-alcoholic fatty liver disease in endometrial cancer. Menopause. 2016;23:189–96.
Matsuo K, Machida H, Shoupe D, et al. Ovarian conservation and overall survival in young women with early-stage low-grade endometrial cancer. Obstet Gynecol. 2016;128:761–70.
Matsuo K, Machida H, Stone RL, et al. Risk of subsequent ovarian cancer after ovarian conservation in young women with stage I endometrioid endometrial cancer. Obstet Gynecol. 2017;130(2):403–10.
Walsh C, Holschneider C, Hoang Y, Tieu K, Karlan B, Cass I. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol. 2005;106:693–9.
Gu H, Li J, Gu Y, Tu H, Zhou Y, Liu J. Survival impact of ovarian preservation on women with early-stage endometrial cancer: a systematic review and meta-analysis. Int J Gynecol Cancer. 2017;27(1):77–84.
Lu KH, Daniels M. Endometrial and ovarian cancer in women with Lynch syndrome: update in screening and prevention. Fam Cancer. 2013;12:273–7.
Gallos ID, Yap J, Rajkhowa M, Luesley DM, Coomarasamy A, Gupta JK. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol. 2012;207(4):266.e1–12.
Schmeler KM, Lynch HT, Chen LM, et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med. 2006;354:261–9.
Barakat RR, Bundy BN, Spirtos NM, et al. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2006;24:587–92.
Ayhan A, Taskiran C, Simsek S, et al. Does immediate hormone replacement therapy affect the oncologic outcome in endometrial cancer survivors? Int J Gynecol Cancer. 2006;16:805–8.
Wright JD, Buck AM, Shah M, Burke WM, Schiff PB, Herzog TJ. Safety of ovarian preservation in premenopausal women with endometrial cancer. J Clin Oncol. 2009;27:1214–9.
Wright JD, Jorge S, Tergas AI, et al. Utilization and outcomes of ovarian conservation in pre-menopausal women with endometrial cancer. Obstet Gynecol. 2016;127:101–8.
Baiocchi G, Clemente AG, Mantoan H, et al. Adnexal involvement in endometrial cancer: prognostic factors and implications for ovarian preservation. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08261-8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The author declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Baiocchi, G. ASO Author Reflections: Could Ovarian Preservation be Considered for Young Women with Endometrial Cancer?. Ann Surg Oncol 27, 2827–2828 (2020). https://doi.org/10.1245/s10434-020-08267-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-08267-2